SPIA
GWPH

Steward Partners Investment Advisory’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Steward Partners Investment Advisory’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-233
Closed -$50.5K – 7584
2021
Q1 		$50.5K Sell
233
-117
-33% -$22K ﹤0.01% 1976
2020
Q4 		$40K Hold
350
– – ﹤0.01% 1777
2020
Q3 		$34K Sell
350
-17
-5% -$1.96K ﹤0.01% 1677
2020
Q2 		$45K Hold
367
– – ﹤0.01% 1463
2020
Q1 		$32K Sell
367
-646
-64% -$68.4K ﹤0.01% 1440
2019
Q4 		$105K Sell
1,013
-150
-13% -$16.8K ﹤0.01% 1125
2019
Q3 		$133K Buy
1,163
+100
+9% +$15.2K ﹤0.01% 981
2019
Q2 		$183K Buy
+1,063
New +$184K 0.01% 845
2018
Q4 		– Sell
-731
Closed -$126K – 2431
2018
Q3 		$126K Sell
731
-40
-5% -$5.77K 0.01% 862
2018
Q2 		$108K Buy
771
+131
+20% +$18.6K 0.01% 821
2018
Q1 		$72K Buy
640
+125
+24% +$15.7K ﹤0.01% 872
2017
Q4 		$67K Hold
515
– – 0.01% 737
2017
Q3 		$52K Sell
515
-21
-4% -$2.25K 0.01% 684
2017
Q2 		$53K Buy
536
+40
+8% +$4.3K 0.01% 615
2017
Q1 		$59K Buy
+496
New +$60.8K 0.01% 521

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Steward Partners Investment Advisory's GWPH Position: Q2 2021 in Review

Steward Partners Investment Advisory sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 233 shares — an estimated $50.5K sold.

Steward Partners Investment Advisory first reported a position in GWPH in Q1 2017 and held it in 15 quarters. The position peaked at $183K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Steward Partners Investment Advisory reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 233 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $50.5K.
  • Steward Partners Investment Advisory first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 15 quarters.
  • Steward Partners Investment Advisory's GW Pharmaceuticals Plc American Depositary Shares position peaked at $183K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.